Evaluation of CHROMagar Acinetobacter for detection of enteric carriage of multidrug-resistant Acinetobacter baumannii in samples from critically ill patients.
CHROMagar Acinetobacter was used to screen stool and perineal swabs for enteric carriage of multidrug-resistant Acinetobacter baumannii in samples from critically ill patients. Results were compared with a molecular assay resulting in sensitivity and specificity of culture compared to PCR of 91.7% and 89.6%, respectively.
Division of Infection, Barts & The London NHS Trust, London, United Kingdom.
N C
NC
Gordon
D W
DW
Wareham
D000151:Acinetobacter Infections / Q000175:diagnosis* / Q000382:microbiology; D040981:Acinetobacter baumannii / Q000187:drug effects* / Q000302:isolation & purification*; D001431:Bacteriological Techniques / Q000379:methods*; D002353:Carrier State / Q000175:diagnosis* / Q000382:microbiology; D016638:Critical Illness; D003470:Culture Media / Q000737:chemistry*; D024901:Drug Resistance, Multiple, Bacterial; D005243:Feces / Q000382:microbiology; D006801:Humans; D010502:Perineum / Q000382:microbiology; D012680:Sensitivity and Specificity
D003470:Culture Media